1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
August 7, 2001
--------------
Date of Report (Date of earliest event reported)
OSI PHARMACEUTICALS, INC.
-------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 0-15190 13-3159796
(State or other jurisdiction of (Commission (I.R.S. Employer
incorporation) File Number) Identification No.)
58 SOUTH SERVICE ROAD
MELVILLE, NY 11747
----------------------------------------
(Address of principal executive offices)
(631) 962-2000
--------------------------------------------------
(Registrant's telephone number, including area code)
106 CHARLES LINDBERGH BOULEVARD
UNIONDALE, NY 11553
--------------------------------
(Former name or former address,
if changed since last report.)
2
ITEM 5. OTHER EVENTS
On August 7, 2001, OSI Pharmaceuticals, Inc., a Delaware corporation
(the "Company") announced that it had entered into an agreement to acquire
certain of the pre-clinical research operations of British Biotech plc (LSE:
BBG; Nasdaq: BBIOY) for (pound sterling) 8.7 million (approximately $12.4
million) in cash. Further details regarding the transaction and facility
reorganization are contained in the Company's press release, dated August 7,
2001, attached as Exhibit 99, and incorporated herein by reference.
ITEM 7. EXHIBITS
- --------------------------------------------------------------
EXHIBIT NO. DESCRIPTION
- --------------------------------------------------------------
99 Press release, dated August 7, 2001.
- --------------------------------------------------------------
3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: August 13, 2001 OSI PHARMACEUTICALS, INC.
By: /s/ Robert L. Van Nostrand
----------------------------------
Robert L. Van Nostrand
Vice President and Chief Financial
Officer (Principal Financial Officer)
4
EXHIBIT INDEX
- -------------------------------------------------------------
EXHIBIT NO. DESCRIPTION
- -------------------------------------------------------------
99 Press release, dated August 7, 2001.
- -------------------------------------------------------------